These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 11739600

  • 1. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.
    Andersson M, Konradi C, Cenci MA.
    J Neurosci; 2001 Dec 15; 21(24):9930-43. PubMed ID: 11739600
    [Abstract] [Full Text] [Related]

  • 2. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N, Martín AB, Mendialdua A, Moratalla R.
    Biol Psychiatry; 2006 Jan 01; 59(1):64-74. PubMed ID: 16139809
    [Abstract] [Full Text] [Related]

  • 3. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
    Winkler C, Kirik D, Björklund A, Cenci MA.
    Neurobiol Dis; 2002 Jul 01; 10(2):165-86. PubMed ID: 12127155
    [Abstract] [Full Text] [Related]

  • 4. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ, Jasmin BJ, Chen JS, Iadarola MJ, St-Jean M, Wigle N, Blanchet P, Grondin R, Robertson GS.
    Eur J Neurosci; 1996 Feb 01; 8(2):365-81. PubMed ID: 8714707
    [Abstract] [Full Text] [Related]

  • 5. Effect of antisense FosB and CREB on the expression of prodynorphin gene in rats with levodopa-induced dyskinesias.
    Chen Z, Guan Q, Cao X, Xu Y, Wang L, Sun S.
    J Huazhong Univ Sci Technolog Med Sci; 2006 Feb 01; 26(5):542-4. PubMed ID: 17219962
    [Abstract] [Full Text] [Related]

  • 6. Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
    Cenci MA.
    Amino Acids; 2002 Feb 01; 23(1-3):105-9. PubMed ID: 12373525
    [Abstract] [Full Text] [Related]

  • 7. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
    Svenningsson P, Gunne L, Andren PE.
    Neuroscience; 2000 Feb 01; 99(3):457-68. PubMed ID: 11029538
    [Abstract] [Full Text] [Related]

  • 8. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment.
    Cenci MA, Tranberg A, Andersson M, Hilbertson A.
    Neuroscience; 1999 Feb 01; 94(2):515-27. PubMed ID: 10579213
    [Abstract] [Full Text] [Related]

  • 9. Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.
    Pirker W, Tedroff J, Pontén H, Gunne L, Andrén PE, Hurd YL.
    Exp Neurol; 2001 May 01; 169(1):122-34. PubMed ID: 11312565
    [Abstract] [Full Text] [Related]

  • 10. Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.
    Lundblad M, Vaudano E, Cenci MA.
    J Neurochem; 2003 Mar 01; 84(6):1398-410. PubMed ID: 12614340
    [Abstract] [Full Text] [Related]

  • 11. Levodopoa but not bromocriptine induces AP-1 and creb DNA-binding activity in the dopamine-depleted striatum of the rat.
    Kashihara K, Akiyama K, Ishihara T, Shiro Y, Shohmori T.
    Life Sci; 1996 Mar 01; 58(10):PL 159-70. PubMed ID: 8602107
    [Abstract] [Full Text] [Related]

  • 12. Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment.
    Andersson M, Westin JE, Cenci MA.
    Eur J Neurosci; 2003 Feb 01; 17(3):661-6. PubMed ID: 12581184
    [Abstract] [Full Text] [Related]

  • 13. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
    Ko WK, Martin-Negrier ML, Bezard E, Crossman AR, Ravenscroft P.
    Neurobiol Dis; 2014 Oct 01; 70():138-48. PubMed ID: 24969021
    [Abstract] [Full Text] [Related]

  • 14. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
    Ravenscroft P, Chalon S, Brotchie JM, Crossman AR.
    Exp Neurol; 2004 Jan 01; 185(1):36-46. PubMed ID: 14697317
    [Abstract] [Full Text] [Related]

  • 15. Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats.
    Meadows SM, Conti MM, Gross L, Chambers NE, Avnor Y, Ostock CY, Lanza K, Bishop C.
    Mov Disord; 2018 Nov 01; 33(11):1740-1749. PubMed ID: 30485908
    [Abstract] [Full Text] [Related]

  • 16. Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats.
    Oh JD, Chartisathian K, Ahmed SM, Chase TN.
    J Neurosci Res; 2003 Jun 15; 72(6):768-80. PubMed ID: 12774317
    [Abstract] [Full Text] [Related]

  • 17. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW, Abercrombie ED.
    J Neurochem; 1999 Apr 15; 72(4):1516-22. PubMed ID: 10098856
    [Abstract] [Full Text] [Related]

  • 18. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA, Lee CS, Björklund A.
    Eur J Neurosci; 1998 Aug 15; 10(8):2694-706. PubMed ID: 9767399
    [Abstract] [Full Text] [Related]

  • 19. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb 15; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 20. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum.
    Cole RL, Konradi C, Douglass J, Hyman SE.
    Neuron; 1995 Apr 15; 14(4):813-23. PubMed ID: 7718243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.